{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:13:15Z","timestamp":1788952395727,"version":"build-2803163510"},"reference-count":23,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T00:00:00Z","timestamp":1160006400000},"content-version":"vor","delay-in-days":5848,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[1990,10]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> The human neuroblastoma clonal cell line SH\u2010SY5Y expresses both \u03bc\u2010 and \u03b4\u2010opioid receptors (ratio \u223c4.5:1). Differentiation with retinoic acid (RA) was previously shown to enhance the inhibition of adenylyl cyclase (AC) by \u03bc\u2010opioid agonists. We tested here the inhibition of cyclic AMP (cAMP) accumulation by morphine under a variety of conditions: after stimulation with prostaglandin E<jats:sub>1<\/jats:sub> (PGE,), forskolin, and vasoactive intestinal peptide (VIP), both in the presence and in the absence of the phosphodiesterase inhibitor 3\u2010isobutyl\u20101\u2010methylxanthine (IBMX). Morphine inhibition of the forskolin cAMP response (\u223c65%) was largely unaffected by the presence of IBMX. In contrast, deletion of IBMX enhanced morphine's inhibition of the PGE, and VIP cAMP response from \u223c50 to \u223c80%. The use of highly \u03bc\u2010 and \u03b4\u2010selective agents confirmed previous results that inhibition of cAMP accumulation by opioids is mostly \u03bc, and not \u03b4, receptor mediated in SH\u2010SY5Y cells, regardless of the presence or absence of IBMX. Because of the large morphine inhibition and the high cAMP levels even in the absence of IBMX, PGE,\u2010stimulated, RA\u2010differentiated SHSY5Y cells were subsequently used to study narcotic analgesic tolerance and dependence in vitro. Upon pretreatment with morphine over 12h, a fourfold shift of the PGE,\u2010morphine dose\u2010response curve was observed, whether or not IBMX was added. However, \u03bc\u2010opioid receptor number and affinity to the \u03bc\u2010selective [D\u2010Ala<jats:sup>2<\/jats:sup>, <jats:italic>N<\/jats:italic>\u2010Me\u2010Phe<jats:sup>4<\/jats:sup>, Gly<jats:sup>5<\/jats:sup>\u2010ol]enkephalin were largely unaffected, and Na<jats:sup>+<\/jats:sup>\u2010 and guanyl nucleotide\u2010induced shifts of morphine\u2010[<jats:sup>3<\/jats:sup>H]naloxone competition curves were unchanged. Further, morphine pretreatment elicited an AC rebound effect, causing higher cAMP accumulation after the drug was removed from the medium or acutely antagonized by naloxone. These results document biochemical correlates of \u03bc\u2010opiate tolerance and dependence in SH\u2010SY5Y cells.<\/jats:p>","DOI":"10.1111\/j.1471-4159.1990.tb03151.x","type":"journal-article","created":{"date-parts":[[2006,10,6]],"date-time":"2006-10-06T00:44:20Z","timestamp":1160095460000},"page":"1390-1396","source":"Crossref","is-referenced-by-count":86,"title":["Regulation of Cyclic AMP by the \u03bc\u2010Opioid Receptor in Human Neuroblastoma SH\u2010SY5Y Cells"],"prefix":"10.1111","volume":"55","author":[{"given":"Victor C.","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Eiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dah\u2010Shuhn","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelveh","family":"Lameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Sad\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,10,5]]},"reference":[{"key":"e_1_2_2_2_1","first-page":"753","article-title":"Role of high affinity cAMP phosphodiesterase activities in the response of S49 cells to agonists","volume":"32","author":"Barber R.","year":"1987","journal-title":"Mol. Pharmacol"},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/296446a0"},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/283625a0"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/255159b0"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(84)90470-9"},{"key":"e_1_2_2_7_1","first-page":"395","article-title":"Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms","volume":"26","author":"Evans T.","year":"1984","journal-title":"Mol. Pharmacol"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.18.5680"},{"key":"e_1_2_2_9_1","first-page":"26","article-title":"Opiate regulation of adenosine 3\u2032\u20105\u2032\u2010cyclic monophosphate level in neuroblastoma \u00d7 glioma NG108\u201315 hybrid cells","volume":"23","author":"Law P. Y.","year":"1983","journal-title":"Mol. Pharmacol"},{"key":"e_1_2_2_10_1","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1016\/S0021-9258(17)43014-6","article-title":"Down\u2010regulation of opiate receptor in neuroblastoma \u00d7 glioma NG 108\u201315 hybrid cells","volume":"259","author":"Law P. Y.","year":"1984","journal-title":"J. Biol. Chem"},{"key":"e_1_2_2_11_1","first-page":"310","article-title":"Muscarinic cholinergic receptor\u2010mediated activation of phosphodiesterase","volume":"22","author":"Meeker R. B.","year":"1982","journal-title":"Mol. Pharmacol"},{"key":"e_1_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(86)90007-9"},{"key":"e_1_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)90617-8"},{"key":"e_1_2_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0045-6039(84)90038-1"},{"key":"e_1_2_2_15_1","first-page":"37","article-title":"Isobutylmethylxanthine stimulates adenylate cyclase by blocking the inhibitory regulatory protein. Gi","volume":"34","author":"Parson W. J.","year":"1988","journal-title":"Mol. Pharmacol"},{"key":"e_1_2_2_16_1","first-page":"25","volume-title":"The International Narcotics Research Conference (INRC '89)","author":"Polastron J.","year":"1990"},{"key":"e_1_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(89)90548-1"},{"key":"e_1_2_2_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.8.3092"},{"key":"e_1_2_2_19_1","first-page":"809","article-title":"Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment","volume":"240","author":"Tao P. L.","year":"1987","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_2_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(89)80806-3"},{"key":"e_1_2_2_21_1","first-page":"427","article-title":"Forskolin alters acetylcholine receptor gating by a mechanism independent of adenylate cyclase activation","volume":"34","author":"White M. M.","year":"1988","journal-title":"Mol. Pharmacol"},{"key":"e_1_2_2_22_1","first-page":"350","article-title":"Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells","volume":"245","author":"Yu V. C.","year":"1988","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_2_2_23_1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0021-9258(17)36053-2","article-title":"A human neuroblastoma cell line expresses mu and delta opioid receptor sites","volume":"261","author":"Yu V. C.","year":"1986","journal-title":"J. Biol. Chem"},{"key":"e_1_2_2_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1988.tb01174.x"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.1990.tb03151.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.1990.tb03151.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T02:08:36Z","timestamp":1698026916000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.1990.tb03151.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,10]]}},"alternative-id":["10.1111\/j.1471-4159.1990.tb03151.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.1990.tb03151.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,10]]}}}